Drug & intervention

Abraxane

RxCUI 589511

Clinical trials33
Recruiting3
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

33 shown
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLCNCT06745882 · 2025-06-13
RECRUITING
Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard TherapyNCT07284836 · 2025-02-01
RECRUITING
Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.NCT07394387 · 2025-01-01
RECRUITING
Abequolixron (RGX-104) and Durvalumab in Lung CancerNCT05911308 · 2024-04-01
TERMINATED
Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain MetastasisNCT04639271 · 2021-01-01
UNKNOWN
Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC AdenocarcinomaNCT03361319 · 2020-07-01
WITHDRAWN
ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast CancerNCT03950570 · 2019-05-25
COMPLETED
Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast CancerNCT03647514 · 2018-12-01
UNKNOWN
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast CancerNCT03647280 · 2018-12-01
UNKNOWN
Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast CancerNCT02687490 · 2017-02-24
COMPLETED
Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1NCT02620280 · 2016-04-01
COMPLETED
A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung CancerNCT02662634 · 2016-03-01
WITHDRAWN
Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based ChemotherapyNCT02303977 · 2015-06-26
COMPLETED
LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL CancerNCT02328105 · 2014-12-01
COMPLETED
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerNCT01938833 · 2014-04-01
TERMINATED
Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With PaclitaxelNCT02073487 · 2014-02-01
COMPLETED
T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast CancerNCT02073916 · 2013-10-01
COMPLETED
Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast CancerNCT01822314 · 2013-04-01
COMPLETED
Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast CancerNCT01647672 · 2012-01-01
UNKNOWN
Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)NCT01446016 · 2011-09-01
COMPLETED
Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast CancerNCT01207102 · 2011-08-01
TERMINATED
Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast CaNCT00934895 · 2009-07-15
TERMINATED
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerNCT00821964 · 2008-12-01
COMPLETED
Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast CancerNCT00723125 · 2008-09-01
COMPLETED
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate CancerNCT00521781 · 2007-08-01
TERMINATED
Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast CancerNCT00503906 · 2007-06-01
COMPLETED
Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast CancerNCT00479674 · 2007-05-01
COMPLETED
Abraxane and Alimta in Advanced Solid TumorsNCT00470548 · 2007-04-01
TERMINATED
Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast CancerNCT00442260 · 2007-02-01
COMPLETED
Study of Abraxane and Carboplatin to Treat Small Cell Lung CancerNCT00454324 · 2006-04-01
TERMINATED
Dose Dense Abraxane in Adjuvant Chemotherapy for Breast CancerNCT00308178 · 2006-03-01
COMPLETED
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate CancerNCT00284752 · 2005-08-01
COMPLETED
Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast CancerNCT00107094 · 2005-03-01
COMPLETED

Conditions being studied

Breast Cancer14Metastatic Breast Cancer5Lung Cancer2Male Breast Cancer2Non-Small Cell Lung Cancer2Recurrent Breast Cancer2Stage IV Breast Cancer2Adenocarcinoma of Lung1Advanced Solid Tumor1Breast Neoplasms1Hepatic Artery Infusion1HER2-negative Breast Cancer1HER2-positive Breast Cancer1Inflammatory Breast Cancer1Invasive Ductal Breast Carcinoma1Liver Metastasis of Breast Cancer1Non-small Cell Lung Cancer (NSCLC)1NSCLC, Recurrent1Patients With Stage IV or Recurrent Adenocarcinoma of the Lung1Prostate Cancer1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.